What question did this study set out to answer?

To resolve conflicting literature and determine the prognostic relevance of TP53 mutations across medulloblastoma molecular subgroups.

July 8, 2013Journal of Clinical OncologyOpen Access

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

View Full Paper

Ask AI

Bookmark

To resolve conflicting literature and determine the prognostic relevance of TP53 mutations across medulloblastoma molecular subgroups.
Conducted a subgroup-specific analysis evaluating TP53 mutation distribution and clinical outcomes in medulloblastoma.
TP53 mutations are selectively enriched in the Sonic Hedgehog (SHH) molecular subgroup of medulloblastoma.
In the SHH subgroup, TP53 mutations portend poor clinical outcome and account for a large proportion of treatment failures.

Implication

Subgroup analysis reveals poor survival and treatment failure in TP53-mutant SHH medulloblastoma, indicating a critical need for risk-adapted therapies.

Abstract

Subgroup-specific analysis reconciles prior conflicting publications and confirms that TP53 mutations are enriched among SHH medulloblastomas, in which they portend poor outcome and account for a large proportion of treatment failures in these patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhukova et al. (2013) studied this question.

synapsesocial.com/papers/69db5544498b35d3e6a3cd4e https://doi.org/10.1200/jco.2012.48.5052

View Full Paper

Ask AI

Bookmark

Implication

Subgroup analysis reveals poor survival and treatment failure in TP53-mutant SHH medulloblastoma, indicating a critical need for risk-adapted therapies.

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

Key Points

Implication

Abstract

Discussion

Cite This Study

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading